February 11, 2016—Medicare pays disproportionate share hospitals in the 340B drug discount program 13 percent less on average for separately payable drugs reimbursed through Medicare Part B than it pays other hospitals and physician practices in the Part B market, researchers have found. The new study also shows that 340B DSH hospitals are treating more vulnerable patients than other providers in terms of race, age, disability, and dual eligibility for Medicaid and Medicare.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)